According to Genscript Biotech
's latest financial reports the company has โฌ1.86 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โฌ1.36 B | 10.1% |
2021-12-31 | โฌ1.23 B | 97.62% |
2020-12-31 | โฌ0.62 B | 64.67% |
2019-12-31 | โฌ0.38 B | -22.85% |
2018-12-31 | โฌ0.49 B | 366.49% |
2017-12-31 | โฌ0.10 B | -18.45% |
2016-12-31 | โฌ0.12 B | 36.77% |
2015-12-31 | โฌ94.86 M | 309.65% |
2014-12-31 | โฌ23.15 M |